PL1904522T3 - Sposób oczyszczania G-CSF - Google Patents

Sposób oczyszczania G-CSF

Info

Publication number
PL1904522T3
PL1904522T3 PL06777781T PL06777781T PL1904522T3 PL 1904522 T3 PL1904522 T3 PL 1904522T3 PL 06777781 T PL06777781 T PL 06777781T PL 06777781 T PL06777781 T PL 06777781T PL 1904522 T3 PL1904522 T3 PL 1904522T3
Authority
PL
Poland
Prior art keywords
csf
chromatography
purification
recovery
followed
Prior art date
Application number
PL06777781T
Other languages
English (en)
Other versions
PL1904522T5 (pl
Inventor
Arndt Dietrich
Bernhard Janowski
Jörg Schäffner
Ulrich Kurt Blaschke
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36999964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1904522(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PL1904522T3 publication Critical patent/PL1904522T3/pl
Publication of PL1904522T5 publication Critical patent/PL1904522T5/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Gyroscopes (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Detergent Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Graft Or Block Polymers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06777781T 2005-07-15 2006-07-14 Sposób oczyszczania G-CSF PL1904522T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005033250A DE102005033250A1 (de) 2005-07-15 2005-07-15 Verfahren zur Reinigung von G-CSF
EP06777781.3A EP1904522B2 (de) 2005-07-15 2006-07-14 Verfahren zur reinigung von g-csf
PCT/EP2006/064263 WO2007009950A1 (de) 2005-07-15 2006-07-14 Verfahren zur reinigung von g-csf

Publications (2)

Publication Number Publication Date
PL1904522T3 true PL1904522T3 (pl) 2009-07-31
PL1904522T5 PL1904522T5 (pl) 2021-01-25

Family

ID=36999964

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06777781T PL1904522T5 (pl) 2005-07-15 2006-07-14 Sposób oczyszczania G-CSF

Country Status (13)

Country Link
US (3) US9815879B2 (pl)
EP (2) EP1904522B2 (pl)
JP (1) JP2009501195A (pl)
AT (1) ATE423131T1 (pl)
CA (2) CA2803048C (pl)
DE (2) DE102005033250A1 (pl)
DK (1) DK1904522T4 (pl)
ES (2) ES2322819T5 (pl)
HU (1) HUE027724T2 (pl)
PL (1) PL1904522T5 (pl)
PT (1) PT1904522E (pl)
SI (1) SI2058326T2 (pl)
WO (1) WO2007009950A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005033250A1 (de) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF
CN102482321B (zh) 2009-06-22 2015-06-17 安姆根有限公司 使用化学控制的氧化还原态重折叠蛋白质
WO2010151688A2 (en) * 2009-06-25 2010-12-29 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
PT2341061E (pt) * 2009-12-31 2013-11-05 Arven Ilac Sanayi Ve Ticaret As Um processo novo para a preparação de g-csf (fator de estimulação de colónias de granulócitos)
PT2525787T (pt) 2010-01-19 2017-12-18 Hanmi Science Co Ltd Formulações líquidas para conjugado de g-csf de longa ação
US8703123B2 (en) * 2010-03-17 2014-04-22 Biogenerix Gmbh Method for obtaining biologically active recombinant human G-CSF
KR101831300B1 (ko) * 2010-10-29 2018-02-23 한미사이언스 주식회사 재조합 대장균으로부터 인간 과립구 콜로니 자극인자를 정제하는 방법
RU2440417C1 (ru) * 2011-01-25 2012-01-20 Тезов Владимир Адольфович Способ очистки рекомбинантного гранулоцитарного колониестимулирующего фактора человека
HUP1200172A2 (en) * 2012-03-19 2013-10-28 Richter Gedeon Nyrt Methods for refolding g-csf from inclusion bodies
ES3002087T3 (en) 2014-07-14 2025-03-06 Gennova Biopharmaceuticals Ltd A novel process for purification of rhu-gcsf
US20180086808A1 (en) * 2015-03-16 2018-03-29 Arven Ilac Sanayi Ve Ticaret A.S. A process for preparing g-csf (granulocyte colony stimulating factor)
WO2022245259A1 (ru) * 2021-05-18 2022-11-24 Акционерное общество "ГЕНЕРИУМ" Способ промышленной очистки ромиплостима

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658018A (en) * 1984-03-13 1987-04-14 Immunex Corporation Process for producing homogeneous colony stimulating factor
US4810643A (en) † 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
DE3537708A1 (de) 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
DE3729863A1 (de) 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
CA1340810C (en) 1988-03-31 1999-11-02 Motoo Yamasaki Polypeptide derivatives of human granulocyte colony stimulating factor
DE68929566D1 (de) 1988-05-13 2010-01-28 Amgen Inc Verfahren zur Isolierung und Reinigung von G-CSF
ES2063783T3 (es) † 1988-06-03 1995-01-16 Chugai Pharmaceutical Co Ltd Factor de cristalino humano de estimulacion de colonias de granulocitos y procedimiento para su preparacion.
DE3835350A1 (de) 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
US5104651A (en) 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
US5055555A (en) * 1989-01-05 1991-10-08 Helmut Sassenfeld Purification of G-CSF
DE4014750A1 (de) 1990-05-08 1991-11-14 Boehringer Mannheim Gmbh Muteine des granulozyten-stimulierenden faktors (g-csf)
FR2669646A1 (fr) 1990-11-23 1992-05-29 Lorraine Laminage Procede de traitement d'un effluent aqueux issu d'un procede d'electrozingage, ainsi que procede et installation en comportant application.
DE4242919A1 (de) 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
US5331095A (en) * 1993-04-12 1994-07-19 Scios Nova Inc. Process for purification of basic fibroblast growth factor
KR100212071B1 (ko) 1994-10-08 1999-08-02 유충식 활성형 인 과립구 콜로니 자극인자의 정제방법
KR0160934B1 (ko) 1996-01-15 1998-11-16 성재갑 효모에서 봉입체로 발현된 재조합 인 과립구 콜로니 자극인자의 정제방법
FR2796071B1 (fr) * 1999-07-08 2001-09-07 Hoechst Marion Roussel Inc Procede de purification de facteur de stimulation de colonies de granulocytes
KR100356140B1 (ko) 1999-07-08 2002-10-19 한미약품공업 주식회사 인간 과립구 콜로니 자극인자 변이체 및 이의 생산 방법
US6646110B2 (en) † 2000-01-10 2003-11-11 Maxygen Holdings Ltd. G-CSF polypeptides and conjugates
CN1318443C (zh) 2000-05-16 2007-05-30 博尔德生物技术公司 含游离半胱氨酸残基的蛋白重折叠的方法
US20020142964A1 (en) † 2000-11-02 2002-10-03 Nissen Torben Lauesgaard Single-chain polypeptides
EP1334127A1 (en) 2000-11-02 2003-08-13 Maxygen Aps Single-chain multimeric polypeptides
SI21102A (sl) * 2001-12-19 2003-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za izolacijo biološko aktivnega granulocitne kolonije stimulirajočega dejavnika
US7118675B2 (en) † 2002-02-04 2006-10-10 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
AU2003265235A1 (en) 2002-04-26 2003-12-19 Genetech, Inc. Non-affinity purification of proteins
WO2004001056A1 (en) * 2002-06-24 2003-12-31 Dr. Reddy's Laboratories Ltd. Process for preparing g-csf
EP1527785A1 (en) * 2003-10-27 2005-05-04 Ludwig-Maximilians-Universität München Use of G-CSF for treating ischemia
CN1663962A (zh) 2004-03-01 2005-09-07 重庆富进生物医药有限公司 重组人粒细胞集落刺激因子及其化学修饰物的一步纯化工艺
DE102004041639A1 (de) * 2004-08-27 2006-03-02 Bioceuticals Arzneimittel Ag Verfahren zur Gewinnung von biologisch aktivem humanen G-CSF aus Inclusion Bodies
EP1869078A2 (en) 2005-03-17 2007-12-26 Zenotech Laboratories Limited Process for the purification of recombinant granulocyte-colony stimulating factor
DE102005033250A1 (de) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF

Also Published As

Publication number Publication date
EP1904522B2 (de) 2020-05-27
CA2803048C (en) 2016-09-13
HUE027724T2 (hu) 2016-11-28
ATE423131T1 (de) 2009-03-15
DK1904522T4 (da) 2020-08-17
US20180094036A1 (en) 2018-04-05
CA2614820C (en) 2013-04-16
CA2614820A1 (en) 2007-01-25
ES2545588T3 (es) 2015-09-14
US20210070822A1 (en) 2021-03-11
PT1904522E (pt) 2009-05-21
US10844103B2 (en) 2020-11-24
DE502006002897D1 (de) 2009-04-02
DK1904522T3 (da) 2009-05-25
EP2058326B1 (de) 2015-07-08
EP2058326A1 (de) 2009-05-13
SI2058326T1 (sl) 2015-10-30
SI2058326T2 (sl) 2019-09-30
CA2803048A1 (en) 2007-01-25
US20080260684A1 (en) 2008-10-23
ES2322819T3 (es) 2009-06-29
DE102005033250A1 (de) 2007-01-18
ES2545588T5 (es) 2020-02-13
ES2322819T5 (es) 2021-02-11
WO2007009950A1 (de) 2007-01-25
EP1904522A1 (de) 2008-04-02
JP2009501195A (ja) 2009-01-15
US9815879B2 (en) 2017-11-14
EP1904522B1 (de) 2009-02-18
EP2058326B2 (de) 2019-05-15
PL1904522T5 (pl) 2021-01-25

Similar Documents

Publication Publication Date Title
EA200702210A1 (ru) Способ очистки белков
PL1904522T5 (pl) Sposób oczyszczania G-CSF
IL166438A0 (en) A method for purifying preproinsulin
EP1808220A4 (en) METHOD FOR PRODUCING A REVERSE OSOMOSIS COMPOUND MEMBRANE
EP1557944A4 (en) MULTIBAND FILER MODULE OF SYMMETRIC UNSYMMETRIC TYPE
SG135037A1 (en) Composite semipermeable membrane, and production process thereof
IL177468A (en) Live protein cleansing process to produce botulinum toxin a, b or f purified toxin
WO2013051368A3 (ja) フィルタ及び空気清浄機
EP1568710A3 (en) Antibody purification method
EP2067520A4 (en) METHOD FOR OPERATING A REVERSE OSMOSEMBRANE FILTRATION PLANT AND REVERSE OSMOSEMBRANE FILTRATION PLANT
DE602004019900D1 (de) Gerät für die plasmareinigung in kombination mit plasmaadsorption-perfusion durch verwendung eines trikompartiment-dialysators
CY1110867T1 (el) Μεθοδος για τον καθαρισμο του παραγοντα vii
AU2003275700A1 (en) Composite adsorbent and method for production thereof, and water purification material and water purifier
EP1759754A4 (en) FILTER, METHOD FOR THE PRODUCTION THEREOF AND EXHAUST GAS CLEANING SYSTEM
PL2305361T3 (pl) System oczyszczania gazu
WO2003008337A3 (en) Apparatus and method for softening water by nanofiltration
EP1240200A4 (en) SEPARATION OF FIBRINOGES OF PLASMAPROTEASES
ATE330688T1 (de) Filterelement zum filtrieren von fluiden
MX2010000534A (es) Filtracion por flujo tangencial variable.
BR0311171A (pt) Instalação de filtro
AU2003221496A1 (en) Cartridge filter for purifying gases
ATE419135T1 (de) Verfahren zum reinigen von atmosphärenluft
WO2009063069A3 (en) Protein purification and endotoxin removal
DK1999262T3 (da) Fremgangsmåde til rensning af rekombinant alfa 1-antitrypsin omfattende et anionbytterchromatografitrin
ITRN20030035A1 (it) Filtro componibile per apparati elettrodomestici, in particolare per cappe filtranti.